Anlotinib combined with almonertinib reverses almonertinib resistance in lung adenocarcinoma by inhibiting the c-MET/PI3K/AKT pathway

World Journal of Surgical Oncology · Published 2026-08-05 · DOI 10.1186/s12957-026-04521-1

Free full text

Authors (3)

Dingdan Lu, Bo Peng, Weiwei Ouyang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lu, D., Peng, B., Ouyang, W. (2026). Anlotinib combined with almonertinib reverses almonertinib resistance in lung adenocarcinoma by inhibiting the c-MET/PI3K/AKT pathway. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-026-04521-1

Related articles

• The crisis of manufactured scholarship: confronting AI-driven “letter-bombing” and profile inflation in medical journals · World Journal of Surgical Oncology · 2026 · Same journal
• Pathological subtype dictates survival and failure pattern in laryngeal neuroendocrine neoplasms: a 15-year single-institution experience · World Journal of Surgical Oncology · 2026 · Same journal
• Primary pulmonary osteosarcoma: a case report, literature review and pooled analysis · World Journal of Surgical Oncology · 2026 · Same journal
• LncRNA ACTA2-AS1 acts as a bladder cancer prognostic biomarker and blocks malignant advance via miR-148b-3p/DNAJB4 · World Journal of Surgical Oncology · 2026 · Same journal
• Radioligand therapy, vascular deprivation and surgical resection as a step-up-approach for locally advanced pancreatic neuroendocrine bleeding mass · World Journal of Surgical Oncology · 2026 · Same journal
• Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study · World Journal of Surgical Oncology · 2026 · Same journal
• Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study · World Journal of Surgical Oncology · 2026 · Same journal
• Clinicopathological features, recurrence patterns, and survival outcomes of triple-negative ductal carcinoma in situ: a single-center cohort study · World Journal of Surgical Oncology · 2026 · Same journal
• Non-coding RNA-mediated ferroptosis reprogramming in doxorubicin-resistant breast cancer: mechanistic evidence, subtype vulnerabilities, and translational strategies · World Journal of Surgical Oncology · 2026 · Same journal
• Application of an innovative embedded parallel pancreaticojejunostomy technique in laparoscopic pancreaticoduodenectomy · World Journal of Surgical Oncology · 2026 · Same journal